IRVINE, Calif., Nov. 2, 2023 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced new findings from the Q-FFICIENCY ...
Temperature control allows for the safe use of higher RF power in short bursts, enhancing efficacy and efficiency without compromising safety 1 AFib is the most common type of cardiac arrhythmia ...
Patients reported improvements of 99% in control of AFib and 93.1% relief of symptoms with the QDOT MICRO™ Catheter 1 Temperature control allows for the use of higher radiofrequency power in short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results